← Back
Nuvaira Logo

About this partner
Nuvaira, Inc. is a privately held medical device company that develops therapies to improve outcomes for patients suffering from obstructive lung diseases by addressing underlying disease pathophysiology. Specifically, the company has developed a novel, catheter-based system to treat overactive airway nerves, a common disease underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD). The dNerva® lung denervation system is CE Mark approved. The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA. Nuvaira and dNerva are trademarks of Nuvaira, Inc.

Related news
Ready to be at the epicenter of health innovation?
Join us
Stay informed with the Medical Alley newsletter